Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment ...

A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with ...

Hyderabad: The 84th All India Industrial Exhibition, which is also called Numaish, concluded on Monday. By Sunday, 19.72 lakh ...

Nectar Life Care launches affordable anti-diabetic range to improve accessibility: Our Bureau, Mumbai Tuesday, February 18, 2025, 12:15 Hrs [IST] Nectar Life Care has announced th ...

The Indian phenotype of T2DM patients is associated with clustering of cardiovascular risk factors, increased insulin ...

In 1996, the Food and Drug Administration approved the labeling for metformin (dimethylbiguanide), the only biguanide currently available in the United States. Phenformin, the other previously ...

Kolkata: Prices of 42 medicines, including those used for day-to-day consumption, are likely to change following an order by ...

These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...

NPPA fixes retail price of 42 formulations, revise prices based on review orders: Our Bureau, New Delhi Tuesday, February 11, 2025, 13:30 Hrs [IST] The National Pharmaceutical Pri ...

Here are seven medicinal plant species that have proved their worth in gold and may well have more to give to the future of ...